Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Recent & Breaking News (NDAQ:PMN)

ProMIS Neurosciences advances Alzheimer's disease program targeting neurotoxic forms of tau

Canada NewsWire October 17, 2019

ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy

Canada NewsWire October 8, 2019

ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit

PR Newswire September 16, 2019

ProMIS Neurosciences to Present at HC Wainwright Investment Conference

Canada NewsWire September 3, 2019

ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board

Canada NewsWire August 27, 2019

ProMIS Neurosciences Announces Second Quarter 2019 Results

PR Newswire August 13, 2019

ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders

Canada NewsWire July 24, 2019

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019

Canada NewsWire July 18, 2019

ProMIS Neurosciences to Present Data at 2019 Alzheimer's Association International Conference

Canada NewsWire July 10, 2019

ProMIS Neurosciences' Data for Alzheimer's Disease Clinical Candidate PMN310 Published in Scientific Reports

Canada NewsWire July 9, 2019

Advanced Alzheimer’s Treatment Showcased at Keystone Symposium

Jonathon Brown June 28, 2019

ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies

Canada NewsWire June 27, 2019

ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies

GlobeNewswire June 27, 2019

ProMIS Neurosciences Closing Private Placement

Canada NewsWire June 26, 2019

ProMIS Names Award-Winning Researcher to Advisory Board

Stockhouse Editorial June 19, 2019

ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board

Canada NewsWire June 19, 2019

ProMIS to Present Alzheimer’s Program Data at Premier Event

Stockhouse Editorial June 5, 2019

ProMIS Neurosciences Presents Lead Program for Alzheimer's Disease at Prestigious Keystone Symposia Scientific Conference

Canada NewsWire June 5, 2019

ProMIS Neurosciences' Eugene Williams to Present at JLABS' Conference on Innovations in Neurodegenerative Diseases

Canada NewsWire May 29, 2019

PODCAST: Saving Minds Episode 6

Featured Submission May 28, 2019